Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Tamás Treuer, MD, PhD
JCP
Original Research
Long-Term Antipsychotic Monotherapy for Schizophrenia: Disease Burden and Comparative Outcomes for Patients Treated With Olanzapine, Quetiapine, Risperidone, or Haloperidol Monotherapy in a Pan-Continental Observational Study
December 31, 2008
Martin Dossenbach
,
Jan Pecenak
,
Agata Szulc
, et al
JCP
Letter to the Editor
What Do We Know About Insulin Resistance and Glucose Metabolism in Patients With Schizophrenia Treated With Antipsychotics?
May 15, 2007
Jamie Karagianis
,
Vicki Poole Hoffmann
,
Virginia L. Stauffer
, et al
JCP
Letter to the Editor
Is There a Real Difference Between the First Onset of Efficacy for Atypical Antipsychotic Monotherapies in Acute Bipolar Mania?
October 14, 2005
Tamás Treuer
,
Bruce R. Basson